Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Conmed Q1 2024 Adj EPS $0.79 Beats $0.74 Estimate, Sales $312.273M Beat $306.776M Estimate

Author: Benzinga Newsdesk | April 24, 2024 04:11pm
Conmed (NYSE:CNMD) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.74 by 6.76 percent. This is a 19.7 percent increase over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $312.273 million which beat the analyst consensus estimate of $306.776 million by 1.79 percent. This is a 5.69 percent increase over sales of $295.468 million the same period last year.

Posted In: CNMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist